LICENSE AND COMMERCIALIZATION AGREEMENTLicense and Commercialization Agreement • February 18th, 2014 • Intellipharmaceutics International Inc. • Pharmaceutical preparations • New York
This License and Commercialization Agreement (the “Agreement”) is hereby entered into and effective as of November 21, 2005 (the “Effective Date”) by and between IntelliPharmaCeutics Corp. ("IPC"), a Nova Scotia corporation, with offices located at 30 Worcester Road, Toronto, Ontario, Canada and Par Pharmaceutical, Inc. (“Par”), a Delaware corporation with offices located at 300 Tice Boulevard, Woodcliff Lake, New Jersey 07677, USA. IPC and Par shall each be defined as a “Party” and together as the “Parties” under this Agreement.
